EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudieOpen Access · CC BY 4.0

Comparative Outcomes of Propranolol and Corticosteroids in Infantile Haemangiomas: A Systematic Review and Meta-Analysis

Alma Sato, James W F Burns, Kesavan Sivanesan, Robyn Haysom, David Riese, Ebaney Ghotra, Kangjie R Chua, Sum-Yu C Lee, Hayato Nakanishi, Christian A Than, Kai Yuen Wong

British Journal of Hospital Medicine · 28.10.2026 · 87 (10)

DOI: 10.31083/bjhm54357 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift British Journal of Hospital Medicine, online erschienen am 28.10.2026. Verfasst von Alma Sato und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Nicosia, 2417 Nicosia, Cyprus. Hauptthemen laut MEDLINE: Propranolol, Hemangioma, Adrenal Cortex Hormones. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Background: Infantile haemangiomas (IH) are the most common benign vascular tumours of infancy. Oral propranolol has become the first-line treatment, while corticosteroids remain second-line or adjunctive options when propranolol is contraindicated or insufficient. This meta-analysis provides updated comparative evidence on the efficacy and safety of oral propranolol versus oral and intralesional corticosteroids in paediatric IH.

Methods

A systematic search of Ovid MEDLINE, Embase, Cochrane Library, CINAHL, and other databases was conducted on April 15, 2025, following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Data were synthesised using a random-effects model.

Results

Fifteen studies met inclusion criteria (n = 1841). Propranolol demonstrated a significantly higher overall treatment effectiveness compared to corticosteroids (odds ratio [OR]: 4.96, 95% confidence interval [CI]: 2.19–11.26; p = 0.0001). In subgroup analyses by route, propranolol was superior to oral corticosteroids (OR: 6.56, 95% CI: 1.98–21.73; p = 0.002), but showed no difference compared to intralesional corticosteroids. Overall adverse event odds were lower with propranolol (OR: 0.27, 95% CI: 0.10–0.71; p = 0.008), specifically when compared against oral corticosteroids (OR: 0.17, 95% CI: 0.03–0.88; p = 0.03) and in treatment-related ulceration rates (OR: 0.18, 95% CI: 0.08–0.42; p < 0.0001). No significant differences were observed between treatment groups regarding overall treatment duration, recurrence rate, or surgical resection rate.

Conclusion

Propranolol was associated with greater overall treatment effectiveness and a lower incidence of adverse events than corticosteroids. Greater effectiveness was observed compared with oral corticosteroids, but not intralesional corticosteroids. Intralesional corticosteroids may remain appropriate for selected patients, highlighting the importance of considering corticosteroid route and individual lesion characteristics when selecting treatment. Systematic Review Registration: PROSPERO (CRD420251025754).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropranololHemangiomaAdrenal Cortex HormonesHumansTreatment OutcomeAdministration, OralInfantInjections, IntralesionalSkin Neoplasms

Stichwörter der Autor:innen

capillarycorticosteroidshaemangiomapropranololsafetysystematic reviewtreatment outcomevascular anomalies

Substanzen

PropranololAdrenal Cortex Hormones

Autor:innen und Institutionen

  • School of Medicine, University of Nicosia, 2417 Nicosia, Cyprus.
  • Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Bolton NHS Foundation Trust, BL4 0JR Bolton, UK.
  • Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, CB2 0QQ Cambridge, UK.
  • University Hospitals of North Midlands, ST4 6QG Stoke-on-Trent, UK.
  • Medical School, European University Cyprus, 2404 Nicosia, Cyprus.

Zitieren

APA

Sato, A., Burns, J. W. F., Sivanesan, K., Haysom, R., Riese, D., Ghotra, E., Chua, K. R., Lee, S. C., Nakanishi, H., Than, C. A., & Wong, K. Y. (2026). Comparative Outcomes of Propranolol and Corticosteroids in Infantile Haemangiomas: A Systematic Review and Meta-Analysis. British Journal of Hospital Medicine, 87(10). https://doi.org/10.31083/bjhm54357

Vancouver

Sato A, Burns JWF, Sivanesan K, Haysom R, Riese D, Ghotra E, et al. Comparative Outcomes of Propranolol and Corticosteroids in Infantile Haemangiomas: A Systematic Review and Meta-Analysis. British Journal of Hospital Medicine. 2026;87(10). doi:10.31083/bjhm54357

BibTeX
@article{Sato2026,
  author = {Sato, Alma and Burns, James W F and Sivanesan, Kesavan and Haysom, Robyn and Riese, David and Ghotra, Ebaney and Chua, Kangjie R and Lee, Sum-Yu C and Nakanishi, Hayato and Than, Christian A and Wong, Kai Yuen},
  title = {Comparative Outcomes of Propranolol and Corticosteroids in Infantile Haemangiomas: A Systematic Review and Meta-Analysis},
  journal = {British Journal of Hospital Medicine},
  year = {2026},
  volume = {87},
  number = {10},
  doi = {10.31083/bjhm54357}
}
Kostenlos starten →